NewAmsterdam Pharma vs vTv Therapeutics
NAMS and VTVT side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NAMS and VTVT compare
vTv Therapeutics grew revenue faster over the last twelve months (216600% versus −88.9% for NewAmsterdam Pharma).
vTv Therapeutics keeps more of each dollar of sales as profit, with a net margin of −12.9% compared with −3644% at NewAmsterdam Pharma.
vTv Therapeutics scores higher on the StockData Score (11 against 6 for NewAmsterdam Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NAMS | VTVT |
|---|---|---|
| Size and price | ||
| Market cap | – | $68.4M |
| Share price | $19.39 | $17.29 |
| Change, 1 year | −49.4% | −43.9% |
| Change, 5 years | 98.1% | −67.7% |
| Beta (5Y) | 1.57 | 0.08 |
| Employees | 100 | 26 |
| StockData Score | ||
| Total score | 6 | 11 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 1.9× |
| P/B | – | 0.9× |
| Fair value | – | $44.97 |
| Margin of safety | – | 61.6% |
| Growth | ||
| Revenue growth (TTM) | −88.9% | 216600% (better) |
| Profitability | ||
| Operating margin | −3432% | −25.1% (better) |
| Net margin | −3644% | −12.9% (better) |
| FCF margin | −2018% | – |
| Return on equity | −36.8% | −11.7% (better) |
| Return on invested capital | −1046% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 9.03 | 12.48 (better) |
| Altman Z-score | – | 0.71 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 40.6% |
| Held by insiders | 22.0% | 26.3% |
| Insider net buying, 12 months | −$63.0M | – |
| Short interest, % of float | – | 5.0% |
Go deeper
- NAMS stock overview
- NAMS income statement
- NAMS valuation and score
- VTVT stock overview
- VTVT income statement
- VTVT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.